DDIT3 and metabolic dysfunction-associated steatotic liver disease: Wang Y. et al. (2020) used a non-alcoholic fatty liver disease (NAFLD) mouse model to show that BBR inhibited the palmitic acid (PA) and lipopolysaccharide (LPS)-induced UPR in macrophages, significantly reducing the expression of CHOP mRNA.